Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

INLIF LIMITED Announces Adjournment of Extraordinary General Meeting

INLIF LIMITED Announces Adjournment of Extraordinary General Meeting

INLIF LIMITED announced that its Extraordinary General Meeting of Shareholders originally scheduled for September 8, 2026, was adjourned due to insufficient shareholder attendance to meet quorum requirements. The meeting is set to reconvene on September 15, 2026. Previously submitted votes remain valid, and shareholders who have not yet voted are e…

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

Eledon Pharmaceuticals announced an upcoming oral presentation at the International Congress of The Transplantation Society showcasing long-term safety and efficacy data of its lead investigational drug, tegoprubart, for preventing kidney transplant rejection. The data come from the Phase 2 BESTOW trial and its extension, highlighting the drug's po…

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Cocrystal Pharma announced that the last subject has been dosed in its Phase 1b norovirus challenge study evaluating CDI-988 as a preventive and treatment for norovirus infections. This study is the first clinical trial of a direct-acting antiviral specifically targeting norovirus, aiming to address a significant unmet medical need. CDI-988 has sho…

Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation

Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation

Can-Fite BioPharma announced publication of a peer-reviewed case report detailing the successful treatment of a patient with advanced decompensated liver cirrhosis using their drug Namodenoson, resulting in resolution of ascites and regression of esophageal varices. The patient remained clinically stable for 28 months on treatment before undergoing…

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Telix Pharmaceuticals Limited announced that its senior executives will present at the Morgan Stanley 24th Annual Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company, a global radiopharmaceutical leader in cancer theranostics, aims to showcase its commercial progress and future plans to investo…

Einride Expands Defense Offering With Mission Planning and Operational Decision-Making for Autonomous Logistics

Einride Expands Defense Offering With Mission Planning and Operational Decision-Making for Autonomous Logistics

Einride AB announced a strategic partnership with UNIQAI Systems to enhance its autonomous logistics platform with AI-driven mission planning and operational decision-making capabilities tailored for defense and national security clients. Building on its existing autonomous freight technology and previous collaborations, Einride aims to address a s…

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind Corporation has entered into a licensing and collaboration agreement with Rose Pharma Inc. to develop ROSE-010 Technosphere, a rapid-acting, short-duration inhaled GLP-1 receptor agonist for weight management. MannKind will provide pharmaceutical development and manufacturing support through Phase 1b trials, receive equity in Rose Pharma, …

Sysco Reaffirming Fiscal 2027 Guidance; Introducing $500 Million Multi-Year AI Powered Efficiency Program; Raising Mid-Term Financial Algorithm Targets

Sysco Reaffirming Fiscal 2027 Guidance; Introducing $500 Million Multi-Year AI Powered Efficiency Program; Raising Mid-Term Financial Algorithm Targets

Sysco Corporation reaffirmed its fiscal 2027 financial guidance with expected adjusted EPS growth of 9%-11% and announced a new $500 million multiyear AI-powered efficiency program aimed to reduce structural costs by fiscal 2029. The company also raised its mid-term financial targets for net sales and adjusted EPS growth for fiscal years 2028 and 2…

RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

RadNet, Inc., a leading US outpatient imaging services provider, announced a free webinar on September 19, 2026, focused on prostate cancer risk, screening, diagnosis, and treatment advancements, including the use of prostate MRI and AI. The event aims to educate men and families during Prostate Cancer Awareness Month by featuring expert panelists …

Radware H1 2026 Global Threat Report Shows Web DDoS Attacks Jump More Than 110% as Cyber Threats Accelerate

Radware H1 2026 Global Threat Report Shows Web DDoS Attacks Jump More Than 110% as Cyber Threats Accelerate

Radware Ltd. (NASDAQ: RDWR) released its H1 2026 Global Threat Analysis Report revealing a sharp increase in cyberattack activities, including a 110.6% rise in Web DDoS attacks and a doubling of malicious web application and API attacks compared to 2025. The report emphasizes rapid exploitation of vulnerabilities, accelerated by AI technologies, an…

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

RadNet, Inc., a leading US provider of diagnostic imaging services and related technology solutions, announced that its Executive Vice President and CFO, Mark Stolper, will present at the Morgan Stanley 24th Annual Global Healthcare Conference. The company operates a large network of outpatient imaging centers across multiple US states and offers A…

Kilbourne Graphite Project Advances Through Key Permitting Milestones

Kilbourne Graphite Project Advances Through Key Permitting Milestones

Titan Mining Corporation announced substantial advancements in federal and state permitting processes for its Kilbourne Graphite Project in New York as it remains on track for commercial natural flake graphite production by 2028. The project has received significant federal support, including financing interest from the U.S. Export-Import Bank, and…

Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial

Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial

BridgeBio Pharma announced positive results from their Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia, demonstrating benefits beyond increased growth including stabilization of sleep apnea, reduced ear infections, and improved body composition. The drug maintained sustained growth improvements and safety over three year…

Premium Catering (Holdings) Limited Receives NASDAQ Notice Related to Late Filing of Its Interim Report

Premium Catering (Holdings) Limited Receives NASDAQ Notice Related to Late Filing of Its Interim Report

Premium Catering (Holdings) Limited announced it received a NASDAQ notice for not timely filing its interim report for the half year ended December 31, 2025, resulting in non-compliance with NASDAQ listing rules. The company has 60 days to submit a compliance plan and potentially up to 180 days to regain compliance, failing which it risks delisting…

Zscaler launches Agentic SOC to contain AI-Driven Threats

Zscaler launches Agentic SOC to contain AI-Driven Threats

Zscaler, Inc. launches the Agentic SOC, a next-generation security operations center platform designed with an AI-first approach to proactively reduce cyber exposures and stop AI-powered attacks at machine speed. Integrating frontier AI models from partners like Anthropic and OpenAI, the solution offers unified threat management, advanced zero trus…

Launch of StoneX Trading marks a new era for City Index

Launch of StoneX Trading marks a new era for City Index

StoneX Group Inc. announces the rebranding of the established UK retail trading brand City Index as StoneX Trading. This strategic move integrates City Index under the global StoneX brand, allowing retail traders access to institutional-level market insights and reinforcing StoneX's position in the global financial services market. The transition i…

MulticoreWare and Micware Sign MOU to Explore Potential Collaboration in ADAS Performance Optimization and Physical AI at the Edge

MulticoreWare and Micware Sign MOU to Explore Potential Collaboration in ADAS Performance Optimization and Physical AI at the Edge

Micware Co., Ltd. has signed a Memorandum of Understanding with MulticoreWare, Inc. to explore collaboration in advanced AI technologies aimed at optimizing Advanced Driver Assistance Systems (ADAS) and physical AI at the edge for automotive applications, beginning in Japan. This partnership combines Micware's strong automotive software and OEM rel…

Pharming Group to participate in September investor conferences

Pharming Group to participate in September investor conferences

Pharming Group N.V., a global biopharmaceutical company listed on Euronext Amsterdam and Nasdaq, announced its participation in two major investor conferences in September 2026: the H.C. Wainwright 28th Annual Global Investment Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, both held in New York. CEO Fabrice Chouraqui w…

California Water Service Kicks Off Back-to-School Season With 13th Year of Tap Into Learning Program

California Water Service Kicks Off Back-to-School Season With 13th Year of Tap Into Learning Program

California Water Service Group has announced the kickoff of the 13th annual Tap Into Learning program, a conservation education initiative designed to engage K-12 students in water stewardship and sustainability. The program includes field trips, art competitions, grants, and pledge campaigns to encourage water conservation across its service areas…

XORTX Re-Engages Investor Relations Program

XORTX Re-Engages Investor Relations Program

XORTX Therapeutics Inc., a pharmaceutical company focused on developing treatments for gout and kidney diseases, has re-engaged IR Agency LLC to provide investor relations and marketing services after its voluntary delisting from the TSX Venture Exchange. The company is advancing several clinical and pre-clinical stage drug programs targeting gout,…

Battalion Oil Corporation Announces Strategic Investment in Collide, the AI-Native Operations System for Oil and Gas

Battalion Oil Corporation Announces Strategic Investment in Collide, the AI-Native Operations System for Oil and Gas

Battalion Oil Corporation announced a strategic equity investment and partnership with Collide Industrial Technologies, gaining priority access to Collide's AI-native operations system designed specifically for the oil and gas sector. The collaboration aims to automate engineering and operational workflows, unlock data from legacy systems, and impr…